IE33318L - Bile acid binding process - Google Patents

Bile acid binding process

Info

Publication number
IE33318L
IE33318L IE691293A IE129369A IE33318L IE 33318 L IE33318 L IE 33318L IE 691293 A IE691293 A IE 691293A IE 129369 A IE129369 A IE 129369A IE 33318 L IE33318 L IE 33318L
Authority
IE
Ireland
Prior art keywords
acid
bile
taurine
resin
acid binding
Prior art date
Application number
IE691293A
Other versions
IE33318B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE33318L publication Critical patent/IE33318L/en
Publication of IE33318B1 publication Critical patent/IE33318B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,262,556. Bile-acid binding compositions. BRISTOL-MYERS CO. 19 Sept., 1969 [20 Sept., 1968], No. 46240/69. Heading A5B. A composition for binding bile-acid in the digestive tract of a taurine/bile acid conjugatesecreting animal (or human) comprises a non- toxic, bile-acid binding anion exchange resin and taurine or a salt or a precursor thereof (e.g. cysteine, cysteine-sulphinic acid, hypotaurine and methionine). The preferred resin is cholesstyramine; others mentioned include polystyrene resins cross-linked with divinyl benzene and containing amino acid addition salt or quaternary ammonium exchange groups, certain cellulose and dextran derivatives and polyethylene imine resins. The invention also comprises the treatment of non-human animals for the above-mentioned purpose by concamitantly administering thereto the resin and taurine or taurine derivative. [GB1262556A]
IE1293/69A 1968-09-20 1969-09-15 Intestinal bile acid binding process and compositions IE33318B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76111568A 1968-09-20 1968-09-20

Publications (2)

Publication Number Publication Date
IE33318L true IE33318L (en) 1970-03-20
IE33318B1 IE33318B1 (en) 1974-05-15

Family

ID=25061185

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1293/69A IE33318B1 (en) 1968-09-20 1969-09-15 Intestinal bile acid binding process and compositions

Country Status (9)

Country Link
AT (1) AT296497B (en)
BE (1) BE739142A (en)
BR (1) BR6912543D0 (en)
DE (1) DE1947670A1 (en)
FR (1) FR2018540B1 (en)
GB (1) GB1262556A (en)
IE (1) IE33318B1 (en)
IL (1) IL33008A (en)
PH (1) PH9499A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof

Also Published As

Publication number Publication date
FR2018540A1 (en) 1970-05-29
GB1262556A (en) 1972-02-02
PH9499A (en) 1976-01-09
DE1947670A1 (en) 1970-04-02
FR2018540B1 (en) 1973-01-12
IL33008A0 (en) 1969-11-30
AT296497B (en) 1972-02-10
IL33008A (en) 1973-02-28
BE739142A (en) 1970-03-02
IE33318B1 (en) 1974-05-15
BR6912543D0 (en) 1973-05-10

Similar Documents

Publication Publication Date Title
Connor et al. Transbilayer movement of phosphatidylserine in erythrocytes: inhibition of transport and preferential labeling of a 31 000-dalton protein by sulfhydryl reactive reagents
IE33318L (en) Bile acid binding process
US4216143A (en) Soluble non-ferrous metal proteinates
DE2962619D1 (en) 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts thereof, processes for their preparation, and pharmaceutical compositions containing such compounds
IE800781L (en) Amino acids and analogues
DE3071358D1 (en) Quinolinyloxy(amino)phenoxyalkane carboxylic acid derivatives, process for their synthesis, herbicidal compositions containing them and their use as herbicides
Levander et al. Studies on the binding of selenium by liver homogenates from rats fed diets containing either casein or casein plus linseed oil meal
PT65521B (en) "N-TE TRAHYDROFURFURYL-NOROXYMORPHONE OF THE SOLE ADDITIONAL SALT, MEDICAMENTS CONTAINING THEM AND METHOD OF PREPARING THEM
US3066077A (en) Alpha, alpha'-dimercaptoadipic hair waving compositions
ATE8387T1 (en) OXINDOL DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND MEDICATIONS WITH NEUROANABOLIC ACTIVITIES CONTAINING THEM.
NL190371C (en) CYCLOAL CANON OXIMETHERS WITH THERAPEUTIC PROPERTIES AND ACID ADDITION SALTS AND QUATERNARY AMMONIUM DERIVATIVES THEREOF, INCLUDING PHARMACEUTICAL COMPOSITIONS, CONTAINING THESE COMPOUNDS, AND PROCESS FOR THE PREPARATION OF THE COMPOUND.
NL7903352A (en) PROCESS FOR PREPARING CYCLOHEXANE CARBONIC ACID DERIVATIVES AND PROCESS FOR PREPARING PHARMA-CEUTIC PREPARATIONS THEREOF.
IE33208L (en) Sweetened composition: substituted tryptophane
John et al. Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites
NL7412336A (en) PROCESS FOR THE PREPARATION OF CARBONIC ACID GROUPS-CONTAINING HYDROCARBON RESINS AND THEIR USE AS A BINDING AGENT.
US4042689A (en) Alkylated orgotein
IE38114B1 (en) Anti-smoking chewing gum preparation
Konat et al. Effect of triethyllead on post-translational processing of myelin proteins
ES389894A1 (en) Manufacture of natural amino acid mixtures from protein materials
AU5442580A (en) Amino acid derivatives of 2,3 dioxopiperazine
GB1222294A (en) Oxazinobenzodiazepine derivatives
GB1313585A (en) Fungicidally and fungistatically active thiocarbonates
ES436133A1 (en) Procedure for the preparation of tiazolidin-4-arginine carboxylate. (Machine-translation by Google Translate, not legally binding)
RU96121905A (en) APPLICATION OF AQUEOUS SOLUTIONS OF L-TRIPTOPHANE AND L-THREONIN SALTS
GB1148758A (en) Substituted ªÐ-aminobenzamides, their preparation and use